Recruiting PHASE4 INTERVENTIONAL 2-arm NCT05444699

Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Less Than 2 Years of Age (RhinoPOCRCT)

Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Less Than 2 Years of Age: a Point-of-care Testing Guided Randomized, Double-blind, Placebo-controlled Trial

Sponsor: University of Oulu

Conditions Bronchiolitis Acute Viral

Interventions Prednisolone Sodium Phosphate Sugar syrup

Updated 7 times since 2022 Last updated: Feb 11, 2025 Started: Oct 11, 2022 Primary completion: Dec 31, 2026 Completion: Sep 30, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05444699, this PHASE4 trial focuses on Bronchiolitis Acute Viral and remains actively recruiting participants. Sponsored by University of Oulu, it has been updated 7 times since 2022, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

7 versions recorded

Mar 2025 — Present [monthly]

Recruiting PHASE4
Sep 2024 — Mar 2025 [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4
Feb 2024 — Jul 2024 [monthly]

Recruiting PHASE4
Nov 2023 — Feb 2024 [monthly]

Recruiting PHASE4

▶ Show 2 earlier versions

Dec 2022 — Nov 2023 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Sep 2022 — Dec 2022 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Oulu

Data source: University of Oulu

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kokkola, Finland
• Oulu, Finland